Promacta 25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM3DM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,235
Award facts
- Contract value 100% obligated
- $10,235.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,235.14 to Amerisourcebergen Drug Corp for the supply of Promacta 25 mg tablets (30-count units) on January 26, 2026. This non-set-aside, firm fixed-price delivery order is scheduled for completion by February 17, 2026, with performance fulfilled from the contractor's Conshohocken, Pennsylvania location. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs across military and veteran healthcare systems.
This delivery order represents a task order execution under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contractor's competitive position within the federal pharmaceutical supply chain is reinforced by DLA Troop Support's plans to establish multiple regional Pharmaceutical Prime Vendor Global Program Generation V contracts, with the potential for at least three different contractors to serve this strategic function.
Quick answers
Who was awarded contract SPE2DR26FM3DM?
SPE2DR26FM3DM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FM3DM worth?
The government has obligated $10,235 on SPE2DR26FM3DM.
Is contract SPE2DR26FM3DM an order under another contract?
Yes. SPE2DR26FM3DM is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3DM competed?
The extent of competition for SPE2DR26FM3DM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award